Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02910505 · ClinicalTrials.gov registry record · NA
A Study of a Novel Multi-Wavelength Laser for Tattoo Removal
A NA study, sponsored by Cutera.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT02910505: Completed NA study, sponsored by Cutera.
NCT02910505 is a NA study that has completed, run by Cutera. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02910505, a NA study, has completed, sponsored by Cutera.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
Single center study to evaluate the safety and efficacy of an investigational version of the Cutera enlightenTM laser that offers multiple wavelengths for tattoo removal.
Primary Outcome
Degree of tattoo clearing at 6 weeks post-final treatment as assessed by the Investigator (Physician's Global Assessment of Improvement). 4= Very Significant or Complete Clearing 3= Significant Clearing 2= Moderate Clearing 1= Mild Clearing 0= No Clearing Higher scores indicate better outcomes
Interventions
- DEVICE enLighten Laser
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2016-10 |
| Est. Completion | 2017-07-28 |
| Phase | NA |
What the finished NCT02910505 record still lists
NCT02910505 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which enLighten Laser is the first listed.
NCT02910505 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02910505 about?
NCT02910505 is a clinical study titled "A Study of a Novel Multi-Wavelength Laser for Tattoo Removal". Single center study to evaluate the safety and efficacy of an investigational version of the Cutera enlightenTM laser that offers multiple wavelengths for tattoo removal.
What is the current status of trial NCT02910505?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2016-10. Estimated completion is 2017-07-28.
What interventions are being tested in trial NCT02910505?
The interventions under investigation include: enLighten Laser (DEVICE).
Who is sponsoring clinical trial NCT02910505?
This trial is sponsored by Cutera, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02910505's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia